112809-51-5 (来曲唑,Letrozole)

来曲唑;1-[双(4-氰基苯基)甲基]-1,2,4-三氮唑;4,4'-(1 H-1,2,4-三唑-1-基亚甲基)-双苯腈;1-[双（4-氰基苯基）甲基]-1,2,4-三唑;4-氯甲基苯硼酸频那醇酯;阿那曲唑;氟康唑;来曲唑 EP标准品;来曲唑 Letrozole;来曲唑 USP;来曲唑 USP标准品;来曲唑 标准品;来曲唑(标准品)：来曲唑（治疗乳腺癌）USP 仅供出口;来曲唑-D4;左旋咪唑 标准品;来曲唑 1-[双(4-氰基苯基)甲基]-1,2,4-三氮唑;来曲唑D4;来曲唑(标准品);来曲唑，医药级,纯度:>99%;20MG/50MG/1KG;来曲唑杂质;来曲唑(分析标准品);

4,4'-((1H-1,2,4-Triazol-1-yl)methylene)dibenzonitrile;4,4'-(1H-1,2,4-TRIAZOL-1-YLMETHYLENE) BIS-BENZONITRILE;CGS-20267;FEMARA;LETROZOL;LetrozoleUsp28;CGS-20267, Femara;LETRAZOLE;letrozolex;Lelrozol;1-[BIS(4-CYANOPHENYL)METHYL]-1,2,4-TRIAZOLE;4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile;4,4'-(1H-1,2,4-Triazole-1-ylmethylene)bisbenzonitrile;4,4'-[(1H-1,2,4-Triazole-1-yl)methylene]dibenzonitrile;Letrozole;4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile;4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile;4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;Letrozole (Femara);[14C]-Letrozole;4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis(benzonitrile);CGS20267;Femera;Letoval;UNII-7LKK855W8I;4,4′-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile;Letroz;Lerozole;Letrozole99%;Letrozole Impurity;CGS 20267;4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile;Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-;C17H11N5;4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE;7LKK855W8I;4,4'-(1h-1,2,4-triazol-1-yl;4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisben;Femara (TN) (Novartis);LETROZOLE [HSDB];HMS2089L22;LETROZOLE [INN];KS-1269;LETROZOLE [EP MONOGRAPH];SPBio_003070;112809-51-5;LETROZOLE [WHO-DD];LETROZOLE [MI];HMS2233C23;letrozolum;BCP0726000213;MFCD00866241;4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile;HMS2051E08;LETROZOLE [USP MONOGRAPH];NSC759652;LETROZOLE (MART.);BCP9000848;AB00514009;BIDD:PXR0130;LETROZOLE (USP MONOGRAPH);AMY32541;EX-A965;LETROZOLE [JAN];LETROZOLE [MART.];HMS3715M11;HMS1571M11;1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole;4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile);Femara, Letrozole;D00964;EN300-264820;LETROZOLE (EP MONOGRAPH);NCGC00016973-01;C08163;LETROZOLE (USP-RS);BL164620;DTXCID503202;BCP23354;Q-201291;Prestwick1_001025;FEM-345;NSC 759652;4,2,4-Triazol-1-ylmethylene)dibenzonitrile;DB01006;SCHEMBL4331;LETROZOLE [ORANGE BOOK];MLS001424038;Letrozole- Bio-X;Letrozole, United States Pharmacopeia (USP) Reference Standard;CHEMBL1444;NCGC00257460-01;4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile;W-60273;Tox21_110719;AB07525;Pharmakon1600-01502354;SW197294-4;AB00514009-08;NCGC00016973-03;HMS3651K05;4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile;Z1741968261;LETROZOLE [USP-RS];CCG-100849;F2173-0288;L0248;AB00514009-07;LETROZOLE [USAN];BPBio1_001331;NCGC00016973-02;Prestwick3_001025;BSPBio_001209;CHEBI:6413;SMR000466343;KISQALI FEMARA CO-PACK COMPONENT LETROZOLE;s1235;AC-1193;NS00000663;HMS3369E11;Letrozole, >=98% (HPLC);BRD-K88789588-001-03-2;MLS006010040;Letrozole, European Pharmacopoeia (EP) Reference Standard;MLS002584991;Femara (TN);GTPL5209;1-Bis(4-cyanophenyl)methyl-1,2,4-triazole;AKOS005145822;Q194974;SR-01000759382-5;SR-01000759382;LETROZOLE (EP IMPURITY);HMS3393E08;NSC-719345;4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE;Prestwick2_001025;Letrozole (JAN/USP/INN);Letrozole [USAN:USP:INN:BAN];AB00514009_10;4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile;CAS-112809-51-5;LETROZOLE COMPONENT OF KISQALI FEMARA CO-PACK;HSDB 7461;AB00514009_11;Letrozole Tablets;LETROZOLE [EP IMPURITY];NC00099;AB00514009-09;DTXSID4023202;CS-1776;NSC-759652;Letrozole (USAN:USP:INN:BAN);HY-14248;A25380;SR-01000759382-4;Tox21_303572;NSC719345;BDBM13061;CCRIS 8822;Prestwick0_001025;MLS000759455;HMS2098M11;NCGC00016973-06;BIDD:GT0015;AB00514009-05;L02BG04;Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material;STL451047;Letrozole?;BRD-K88789588-001-14-9;

MFCD00866241

HPJKCIUCZWXJDR-UHFFFAOYSA-N

1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H

N1(C=NC=N1)C(C1C=CC(C#N)=CC=1)C1C=CC(C#N)=CC=1

7461

2933990090